• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Seasonal trends and molecular evolution of SARS-CoV-2 in acute respiratory illness patients during the fifth year of COVID-19, Thailand

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Oct 13;15(1):35703.
doi: 10.1038/s41598-025-19609-z. Seasonal trends and molecular evolution of SARS-CoV-2 in acute respiratory illness patients during the fifth year of COVID-19, Thailand

Jiratchaya Puenpa[SUP] 1 [/SUP], Preeyaporn Vichaiwattana[SUP] 1 [/SUP], Ratchadawan Aeemjinda[SUP] 1 [/SUP], Lakkhana Wongsrisang[SUP] 1 [/SUP], Sumeth Korkong[SUP] 1 [/SUP], Jen-Ren Wang[SUP] 2 3 4 [/SUP], Nasamon Wanlapakorn[SUP] 5 [/SUP], Yong Poovorawan[SUP] 6 7 [/SUP]



Affiliations
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is relentlessly evolving, with emerging variants exhibiting heightened transmissibility and immune escape capabilities. Understanding the genetic diversity and seasonal transmission dynamics of SARS-CoV-2 in Thailand is crucial for implementing effective public health interventions. This study aims to elucidate the genetic diversity and seasonal transmission patterns of SARS-CoV-2 among patients with acute respiratory illness in Thailand in 2024. Among 8,096 Acute Respiratory Infection (ARI) cases analyzed, 1,152 samples tested positive for SARS-CoV-2, resulting in a positivity rate of 14.2%. The majority of infections occurred during a significant Outbreak from late summer to early rainy season, particularly between April and June, accounting for nearly 49% of all positive cases. The highest infection rate occurred in adults aged 31-40 years, with no significant association between gender and infection status (p = 0.583). Extensive genomic sequencing identified over seven distinct SARS-CoV-2 lineages, with the JN.1 lineage dominating early in the year. Recombinant variants, notably XEC, XDV.1, and XDY, emerged as significant contributors to the evolving landscape, reaching a prevalence of 57.1% by December. Phylogenetic analyses demonstrated a consistent evolutionary rate and identified critical emergence dates for new lineages, underscoring the virus's ongoing evolution in Thailand. Our findings emphasize the necessity of continuous genomic surveillance for tracking variant transmission dynamics and managing public health responses effectively. Furthermore, the evolving genetic landscape of SARS-CoV-2 highlights the urgent need for adaptive vaccination strategies aligned with seasonal transmission patterns in Thailand.

Keywords: COVID-19; Genomic surveillance; Molecular evolution; SARS-CoV-2; Seasonal transmission; Thailand.

 
Back
Top Bottom